1.19
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Displaying 1 - 10 of 7022
Penn In the News
Trump-friendly Newsmax bundled into Comcast’s Xfinity service
The Annenberg School for Communication’s Victor Pickard discussed conservative news channel Newsmax and its recent deal with Comcast. If Comcast is “feeling the heat from the right, it will make sense to appease some of those critics,” said Pickard.
Penn In the News
The brain’s traffic problems
James Shorter of the Perelman School of Medicine was cited for research about breaking up “stress granules,” tiny packets of protein and RNA that form during cellular stress, which can accumulate in, and ultimately harm, people with ALS or frontotemporal dementia. Shorter’s work aims to equip cells with a gene that would prevent that accumulation.
Penn In the News
ACA contraceptive coverage
Allison Hoffman of the Law School discussed the significance of a ruling by a federal judge in Philadelphia that stopped the expansion of employer exemptions for covering contraception on religious or moral grounds.
Penn In the News
Arrivals: Books that show women rock the world
Kristen Ghodsee of the School of Arts and Sciences was highlighted for her new book, Why Women Have Better Sex Under Socialism and Other Arguments for Economic Independence.
Penn In the News
Researchers call for oversight of burgeoning brain stimulation market
In a recent issue of the journal Science, Anna Wexler of the Perelman School of Medicine called for more oversight of brain stimulation devices and apps, which claim to improve cognitive performance. “We just don’t know what the long-term effects of brain stimulation are,” said Wexler.
Penn In the News
An unlikely treatment offers hope for chronic pains sufferers but drug makers see little incentive
Patricia Danzon of the Wharton School commented on drug companies’ hesitance to produce new medications. “Bringing a new drug to market requires getting FDA approval and that requires doing clinical trials,” she said. “That’s a significant investment, and companies, unsurprisingly, are not willing to do that unless they can get a patent and be the sole supplier of that drug for at least some period of time.”
Penn In the News
Raymond G. Perelman, master investor and philanthropist, dies at 101
Businessman, philanthropist, and Wharton alum Raymond G. Perelman died at the age of 101. His gifts “helped advance Penn’s position as a global model for comprehensive academic medical centers,” said President Amy Gutmann.
Penn In the News
16 big predictions about 2019, from Trump’s impeachment to the rise of AI
Wharton’s Philip Tetlock was cited for his research on “superforecasters,” people who appear to be systematically better at predicting world events. Common traits among those people include lots of practice and an openness to being wrong.
Penn In the News
Houston police team up with Ring app to tackle crime
Maria Cuellar of the School of Arts and Sciences commented a partnership between the Houston Police Department and Ring, a home surveillance company that offers video doorbells, saying that there is not enough evidence to claim that the devices reduce crime.
Penn In the News
Bill de Blasio and Gavin Newsom may give restrictionism new life
Daniel Hopkins of the School of Arts and Sciences was cited for his research on the nationalization of U.S. politics, as published in his book The Increasingly United States: How and Why American Political Behavior Nationalized.